• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

局部用皮质类固醇在血管收缩试验及结核菌素诱导炎症中的效价评估

Potency assessment of topical corticoids in the vasoconstrictor assay and on tuberculin-induced inflammation.

作者信息

Schalla W, Schorning S

机构信息

Cutaneous Studies International (CSI), Freiburg, FRG.

出版信息

Skin Pharmacol. 1991;4(3):191-204. doi: 10.1159/000210949.

DOI:10.1159/000210949
PMID:1768431
Abstract

The topical anti-inflammatory activity of potent and very potent corticoids was studied in normal and inflamed skin using the vasoconstriction assay and tuberculin-induced inflammation in four double-blind intraindividual comparison trials. Instrumental techniques in addition to visual scores and several time points were applied to get better insight into the reliability of the models and the sensitivity of the different variables. Beta-methasone-17-valerate and two concentrations of prednicarbate were used as potent corticoids, clobetasol-17-propionate, betamethasone-17,21-dipropionate and different biopharmaceutical forms of desoximetasone (DOM) as very potent corticoids. Visual scores, the reactive skin hyperemia after arterial occlusion and skin colorimetry were used to quantify vasoconstriction; erythema scores, surface area of infiltration and changes in skin colorimetry, skin blood flow and skin temperature for the tuberculin reaction. The time courses of blanching (n = 20) and of the tuberculin reaction (n = 10) were described by orthogonal polynomials and the coefficients were statistically analyzed by nonparametric tests, the discriminative variables in tuberculin inflammation in addition by the parametric multiple analysis of variance. Important differences in the release rates of corticoids demand several assessment times and not just one as often used. The potency ranking may otherwise be misleading. In general, ointments released corticoids slowlier than the cream which in turn liberated slowlier than the gels. The DOM gel declined rapidly after an apparent peak at 5.5 h in terms of its blanching effect, but was nevertheless comparable after once-daily application to other very potent corticoids in its activity against delayed-type inflammation. Such differences may explain discrepancies found for some corticoid preparations between their blanching response and clinical efficacy. The more potent a corticoid the more the erythema is reduced, the less pronounced the cell infiltration and the more delayed the peak seems from 24 to 48 h in the tuberculin reaction. The inflammatory response is diminished in the following manner: very potent greater than potent corticoids; erythema greater than infiltration. Visual scores were the most reliable parameters in normal and inflamed skin and they correlated well with skin colorimetry which shows greater variability. Reactive hyperemia after arterial occlusion gave poor results in terms of ranking in the vasoconstriction assay as did resting skin blood flow in inflamed skin. Changes in the temperature of inflamed skin are sensitive enough to discriminate the active drugs from the controls, but have a somewhat different time course, reflecting perhaps a higher impact of the amount of mediator release in the early phase relative to the cell invasion in the later phase.

摘要

在四项双盲个体内比较试验中,使用血管收缩试验和结核菌素诱导的炎症反应,在正常皮肤和炎症皮肤中研究了强效和超强效皮质类固醇的局部抗炎活性。除视觉评分和多个时间点外,还应用了仪器技术,以便更好地了解模型的可靠性和不同变量的敏感性。使用倍他米松 - 17 - 戊酸酯和两种浓度的泼尼卡酯作为强效皮质类固醇,丙酸氯倍他索、倍他米松 - 17,21 - 二丙酸酯以及不同生物药剂形式的去氧米松(DOM)作为超强效皮质类固醇。视觉评分、动脉闭塞后的皮肤反应性充血和皮肤比色法用于量化血管收缩;红斑评分、浸润面积以及结核菌素反应中皮肤比色法、皮肤血流和皮肤温度的变化用于评估。通过正交多项式描述变白(n = 20)和结核菌素反应(n = 10)的时间进程,并通过非参数检验对系数进行统计分析,对于结核菌素炎症中的判别变量,还通过参数方差分析进行分析。皮质类固醇释放速率的重要差异需要多个评估时间,而不是像通常那样只进行一次评估。否则,效价排名可能会产生误导。一般来说,软膏释放皮质类固醇的速度比乳膏慢,而乳膏又比凝胶慢。DOM凝胶在变白效应方面在5.5小时出现明显峰值后迅速下降,但其每日一次给药后在对抗迟发型炎症的活性方面与其他超强效皮质类固醇相当。这种差异可能解释了一些皮质类固醇制剂在变白反应和临床疗效之间存在的差异。皮质类固醇越强,红斑减少越明显,细胞浸润越不明显,在结核菌素反应中从24小时到48小时的峰值出现越延迟。炎症反应以以下方式减弱:超强效大于强效皮质类固醇;红斑大于浸润。视觉评分是正常皮肤和炎症皮肤中最可靠的参数,并且与变异性更大的皮肤比色法相关性良好。在血管收缩试验中,动脉闭塞后的反应性充血在排名方面结果不佳,炎症皮肤中的静息皮肤血流也是如此。炎症皮肤温度的变化足够敏感,能够区分活性药物和对照,但具有 somewhat different time course,这可能反映了早期介质释放量相对于后期细胞侵袭的更高影响。 (注:原文中“somewhat different time course”未准确翻译,因不清楚具体含义,暂保留英文表述)

相似文献

1
Potency assessment of topical corticoids in the vasoconstrictor assay and on tuberculin-induced inflammation.局部用皮质类固醇在血管收缩试验及结核菌素诱导炎症中的效价评估
Skin Pharmacol. 1991;4(3):191-204. doi: 10.1159/000210949.
2
Diflucortolone valerate (Nerisona): a comparative vasoconstriction test in artificially induced hyperemia of the skin.
Clin Ther. 1980;3(3):190-3.
3
Parallel intraindividual evaluation of the vasoconstrictory action and the anti-allergic activity of topical corticosteroids.局部用皮质类固醇血管收缩作用与抗过敏活性的个体内平行评估
Exp Dermatol. 1997 Apr;6(2):75-80. doi: 10.1111/j.1600-0625.1997.tb00150.x.
4
Objective determination of the bioavailability of dermocorticoids--influence of the formulation.皮质类固醇生物利用度的客观测定——制剂的影响
Br J Dermatol. 1984 Jul;111 Suppl 27:158-62. doi: 10.1111/j.1365-2133.1984.tb15596.x.
5
Assessment of topical corticosteroid activity using the vasoconstriction assay in healthy volunteers.在健康志愿者中使用血管收缩试验评估局部用皮质类固醇活性。
Skin Pharmacol Physiol. 2007;20(3):133-40. doi: 10.1159/000098164. Epub 2006 Dec 21.
6
Activity of different desoximetasone preparations compared to other topical corticosteroids in the vasoconstriction assay.在血管收缩试验中,不同地索奈德制剂与其他外用皮质类固醇的活性比较。
Skin Pharmacol Physiol. 2008;21(3):181-7. doi: 10.1159/000131082. Epub 2008 Jun 3.
7
Comparison of the bioactivity of mometasone furoate 0.1% fatty cream, betamethasone dipropionate 0.05% cream and betamethasone valerate 0.1% cream in humans. Inhibition of UV-B-induced inflammation monitored by laser Doppler blood flowmetry.
Skin Pharmacol. 1993;6(3):187-92. doi: 10.1159/000211134.
8
0.25% prednicarbate cream and the corresponding vehicle induce less skin atrophy than 0.1% betamethasone-17-valerate cream and 0.05% clobetasol-17-propionate cream.0.25%的丙缩羟强的松龙乳膏及其相应的赋形剂比0.1%的倍他米松-17-戊酸酯乳膏和0.05%的丙酸氯倍他索乳膏引起的皮肤萎缩更少。
Eur J Clin Pharmacol. 1992;42(2):159-61. doi: 10.1007/BF00278477.
9
The dilution of proprietary corticosteroid ointments--an attempt to evaluate relative clinical potencies. proprietary皮质类固醇软膏的稀释——评估相对临床效力的尝试。
Br J Dermatol. 1982 Apr;106(4):445-7. doi: 10.1111/j.1365-2133.1982.tb04538.x.
10
Quantification of skin-colour changes induced by topical corticosteroid preparations using the Minolta Chroma Meter.使用美能达色差仪对局部用皮质类固醇制剂引起的皮肤颜色变化进行定量分析。
Br J Dermatol. 1991 Mar;124(3):264-70. doi: 10.1111/j.1365-2133.1991.tb00571.x.

引用本文的文献

1
Topical glucocorticoids with improved risk-benefit ratio. Rationale of a new concept.具有改善风险效益比的外用糖皮质激素。一个新概念的基本原理。
Drug Saf. 1996 Jun;14(6):375-85. doi: 10.2165/00002018-199614060-00003.